Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2026-01-25 @ 2:44 AM
Study NCT ID:
NCT05469061
Status:
UNKNOWN
Last Update Posted:
2022-07-21
First Post:
2022-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC
Sponsor:
Organization: